尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Auchincloss Thomas G, 董事. Insider active across 1 company, notably Concert Pharmaceuticals, INC.. Cumulatively, 4 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €27k. Activity tracked since 6 June 2022. The latest transaction was filed on 6 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Thomas G. Auchincloss is a Board Member at Concert Pharmaceuticals, Inc. He contributes to the strategic direction of the company, bringing his expertise in biotechnology and product development. His role is essential in supporting innovation and growth.